Alacrita welcomes Dr Martin Pue to the team.
Martin has over 25 years of international experience in the pharmaceutical industry in established and evolving companies and has worked across all aspects of the drug life cycle from discovery to commercialization operating in permanent and interim management roles.
From a solid initial technical grounding in drug metabolism and pharmacokinetics, Martin has worked in most areas of preclinical and clinical drug development and registration. He has directed the non-clinical development through first-in-man and Proof-of-Concept clinical trials of 6 new chemical entities and their subsequent Phase II/III clinical development, primarily using third-party service providers.
His experience spans Big Pharma (SmithKline Beecham) as well as biotech (Antisoma, Vernalis).